|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 324.4 USD | +2.17% |
|
+1.28% | +19.84% |
| Jul. 12 | Bernstein Adjusts Price Target on HCA Healthcare to $362 From $317 | MT |
| Jul. 09 | Barclays Adjusts HCA Healthcare's Price Target to $376 From $367, Keeps Overweight Rating | MT |
HCA Healthcare, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 60,233 million compared to USD 58,752 million a year ago. Net income was USD 5,643 million compared to USD 6,956 million a year ago.
Diluted earnings per share from continuing operations was USD 19.15 compared to USD 21.16 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +19.84% | 84.94B | |
| -25.24% | 74.07B | |
| -1.20% | 26.15B | |
| +4.56% | 18.03B | |
| -9.29% | 17.38B | |
| +4.52% | 16.01B | |
| +78.16% | 13.7B | |
| +77.84% | 13.13B | |
| -26.14% | 12.74B | |
| +35.12% | 12.41B |
HCA HEALTHCARE, INC. 
